226. Interstitial cystitis with Hunners ulcer Clinical trials / Disease details
Clinical trials : 145 / Drugs : 156 - (DrugBank : 51) / Drug target genes : 64 - Drug target pathways : 146
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05726786 (ClinicalTrials.gov) | March 2023 | 16/1/2023 | The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy (INCyst Trial) | The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy - A Multicenter Randomized Controlled Trial (INCyst Trial) | Bladder Cancer;Interstitial Cystitis;Painful Bladder Syndrome;Neurogenic Bladder;Hemorrhagic Cystitis;Endometriosis;Bladder Disease | Drug: Immunonutrition | Centre Hospitalier Universitaire Vaudois | University Hospital Inselspital, Berne;Hôpital Riviera-Chablais, Vaud-Valais | Not yet recruiting | 18 Years | N/A | All | 232 | Phase 3 | Switzerland |